Kenvue Inc
KVUE18.130USD
+0.075+0.42%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
34.73BCap. mercado
24.25P/E TTM
Más Datos de Kenvue Inc Compañía
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Información de Kenvue Inc
Símbolo de cotizaciónKVUE
Nombre de la empresaKenvue Inc
Fecha de salida a bolsaMay 04, 2023
Director ejecutivoPerry (Kirk L)
Número de empleados22000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 04
Dirección1 Kenvue Way
CiudadSUMMIT
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07901
Teléfono19088741200
Sitio Webhttps://www.kenvue.com
Símbolo de cotizaciónKVUE
Fecha de salida a bolsaMay 04, 2023
Director ejecutivoPerry (Kirk L)
Ejecutivos de Kenvue Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
66.04K
+1596.00%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
62.55K
+62555.00%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+17320.00%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
58.09K
+1779.00%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
36.83K
+11583.00%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+4414.00%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
32.65K
+1290.00%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+1563.00%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
10.79K
-17652.00%
Mr. Russell Dyer
Mr. Russell Dyer
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
4.10K
+2397.00%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
66.04K
+1596.00%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
62.55K
+62555.00%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+17320.00%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
58.09K
+1779.00%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
36.83K
+11583.00%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+4414.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
752.80M
20.00%
Other Self Care
602.24M
16.00%
Pain Care
489.32M
13.00%
Cough, Cold and Allergy
489.32M
13.00%
Other Essential Health
414.04M
11.00%
Otro
1.02B
27.00%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
752.80M
20.00%
Other Self Care
602.24M
16.00%
Pain Care
489.32M
13.00%
Cough, Cold and Allergy
489.32M
13.00%
Other Essential Health
414.04M
11.00%
Otro
1.02B
27.00%
Estadísticas de accionistas
Actualizado: mar., 30 de dic
Actualizado: mar., 30 de dic
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.22%
State Street Investment Management (US)
5.99%
T. Rowe Price Associates, Inc.
5.81%
BlackRock Institutional Trust Company, N.A.
5.08%
Fidelity Management & Research Company LLC
3.85%
Otro
67.04%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.22%
State Street Investment Management (US)
5.99%
T. Rowe Price Associates, Inc.
5.81%
BlackRock Institutional Trust Company, N.A.
5.08%
Fidelity Management & Research Company LLC
3.85%
Otro
67.04%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.80%
Investment Advisor/Hedge Fund
26.53%
Hedge Fund
9.50%
Research Firm
3.76%
Pension Fund
1.82%
Sovereign Wealth Fund
1.51%
Bank and Trust
1.17%
Family Office
0.45%
Family Office
0.19%
Otro
1.27%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
2166
1.89B
98.76%
-327.19M
2025Q3
2127
1.94B
100.91%
-295.23M
2025Q2
2098
1.93B
100.46%
-321.30M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
232.47M
12.13%
+85.24K
+0.04%
Sep 30, 2025
State Street Investment Management (US)
114.80M
5.99%
-219.34K
-0.19%
Sep 30, 2025
T. Rowe Price Associates, Inc.
111.36M
5.81%
-52.91M
-32.21%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
97.40M
5.08%
+1.60M
+1.67%
Sep 30, 2025
Fidelity Management & Research Company LLC
73.85M
3.85%
-9.05M
-10.92%
Sep 30, 2025
MFS Investment Management
83.59M
4.36%
-4.04M
-4.61%
Sep 30, 2025
Geode Capital Management, L.L.C.
49.49M
2.58%
+489.37K
+1.00%
Sep 30, 2025
UBS Financial Services, Inc.
22.94M
1.2%
-2.95M
-11.40%
Sep 30, 2025
American Century Investment Management, Inc.
37.05M
1.93%
+6.78M
+22.41%
Sep 30, 2025
Wellington Management Company, LLP
33.79M
1.76%
-12.59M
-27.14%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Renaissance IPO ETF
7.13%
American Century Focused Large Cap Value ETF
3.3%
VanEck Morningstar Wide Moat Value ETF
3.29%
ProShares Ultra Consumer Staples
2.91%
TBG Dividend Focus ETF
2.75%
Brookstone Value Stock ETF
2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.13%
MarketDesk Focused US Dividend ETF
1.93%
Consumer Staples Select Sector SPDR Fund
1.84%
VanEck Morningstar Wide Moat ETF
1.76%
Ver más
Renaissance IPO ETF
Proporción7.13%
American Century Focused Large Cap Value ETF
Proporción3.3%
VanEck Morningstar Wide Moat Value ETF
Proporción3.29%
ProShares Ultra Consumer Staples
Proporción2.91%
TBG Dividend Focus ETF
Proporción2.75%
Brookstone Value Stock ETF
Proporción2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporción2.13%
MarketDesk Focused US Dividend ETF
Proporción1.93%
Consumer Staples Select Sector SPDR Fund
Proporción1.84%
VanEck Morningstar Wide Moat ETF
Proporción1.76%
Dividendos
Un total de
2.32B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 28, 2026
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Feb 25, 2026 going ex on Feb 11, 2026
Feb 11, 2026
Feb 25, 2026
Feb 11, 2026
Oct 29, 2025
KVUE.NB Final Cash Dividend of gross USD 0.2075 paid on Nov 26, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 26, 2025
Nov 12, 2025
Jul 30, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Aug 27, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 27, 2025
Aug 13, 2025
Apr 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on May 28, 2025 going ex on May 14, 2025
May 14, 2025
May 28, 2025
May 14, 2025
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Ver más
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
